Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Primary and secondary arterial fistulas during chronic Q fever.

Karhof S, van Roeden SE, Oosterheert JJ, Bleeker-Rovers CP, Renders NHM, de Borst GJ, Kampschreur LM, Hoepelman AIM, Koning OHJ, Wever PC.

J Vasc Surg. 2018 Dec;68(6):1906-1913.e1. doi: 10.1016/j.jvs.2018.01.044.

PMID:
29685511
2.

Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers.

Bosch T, Lutgens SPM, Hermans MHA, Wever PC, Schneeberger PM, Renders NHM, Leenders ACAP, Kluytmans JAJW, Schoffelen A, Notermans D, Witteveen S, Bathoorn E, Schouls LM.

J Clin Microbiol. 2017 Aug;55(8):2380-2390. doi: 10.1128/JCM.00535-17. Epub 2017 May 17.

3.

Primary Actinomycosis in the breast caused by Actinomyces neuii. A report of 2 cases.

Leenstra BS, Schaap CCM, Bessems M, Renders NHM, Bosscha K.

IDCases. 2017 Apr 1;8:70-72. doi: 10.1016/j.idcr.2017.03.014. eCollection 2017.

4.

Value of 18F-FDG PET/CT in diagnosing chronic Q fever in patients with central vascular disease.

Hagenaars JC, Wever PC, Vlake AW, Renders NH, van Petersen AS, Hilbink M, de Jager-Leclercq MG, Moll FL, Koning OH, Hoekstra CJ.

Neth J Med. 2016 Aug;74(7):301-8.

5.

Chronic Q fever diagnosis— consensus guideline versus expert opinion

Kampschreur LM, Wegdam-Blans MC, Wever PC, Renders NH, Delsing CE, Sprong T, van Kasteren ME, Bijlmer H, Notermans D, Oosterheert JJ, Stals FS, Nabuurs-Franssen MH, Bleeker-Rovers CP; Dutch Q Fever Consensus Group.

Emerg Infect Dis. 2015 Jul;21(7):1183-8.

6.

Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic.

Wielders CC, van Loenhout JA, Morroy G, Rietveld A, Notermans DW, Wever PC, Renders NH, Leenders AC, van der Hoek W, Schneeberger PM.

PLoS One. 2015 Jul 10;10(7):e0131848. doi: 10.1371/journal.pone.0131848. eCollection 2015.

7.

Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis.

Pennings JL, Kremers MN, Hodemaekers HM, Hagenaars JC, Koning OH, Renders NH, Hermans MH, de Klerk A, Notermans DW, Wever PC, Janssen R.

Clin Vaccine Immunol. 2015 Jun;22(6):664-71. doi: 10.1128/CVI.00078-15. Epub 2015 Apr 29.

8.

Vascular chronic Q fever: quality of life.

Hagenaars JC, Wever PC, Shamelian SO, Van Petersen AS, Hilbink M, Renders NH, De Jager-Leclercq GL, Moll FL, Koning OH.

Epidemiol Infect. 2015 Oct;143(13):2903-9. doi: 10.1017/S0950268814003951. Epub 2015 Jan 22.

PMID:
25608699
9.

Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever.

Hagenaars JC, Koning OH, van den Haak RF, Verhoeven BA, Renders NH, Hermans MH, Wever PC, van Suylen RJ.

Int J Exp Pathol. 2014 Aug;95(4):282-9. doi: 10.1111/iep.12086. Epub 2014 Jun 23.

10.

Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak.

Hagenaars JC, Wever PC, van Petersen AS, Lestrade PJ, de Jager-Leclercq MG, Hermans MH, Moll FL, Koning OH, Renders NH.

J Infect. 2014 Aug;69(2):154-60. doi: 10.1016/j.jinf.2014.03.009. Epub 2014 Mar 16.

PMID:
24647145
11.

Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection.

Hagenaars JC, Renders NH, van Petersen AS, Shamelian SO, de Jager-Leclercq MG, Moll FL, Wever PC, Koning OH.

Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1407-14. doi: 10.1007/s10096-014-2084-0. Epub 2014 Mar 12.

PMID:
24619114
12.

Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC.

J Clin Microbiol. 2014 May;52(5):1637-43. doi: 10.1128/JCM.03221-13. Epub 2014 Mar 5.

13.

Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands.

van Wijk MJ, Maas DW, Renders NH, Hermans MH, Zaaijer HL, Hogema BM.

BMC Infect Dis. 2014 Jan 6;14:6. doi: 10.1186/1471-2334-14-6.

14.

Two cases with acute abdominal aneurysm and evidence of acute Q fever infection.

Hagenaars JC, Kampschreur LM, de Jager-Leclercq MG, van Petersen AS, Moll FL, Renders NH, Wever PC, Koning OH, Hoornenborg E.

Ann Vasc Surg. 2014 Feb;28(2):494.e1-3. doi: 10.1016/j.avsg.2013.03.022. Epub 2013 Dec 22.

PMID:
24368182
15.

High Coxiella burnetii DNA load in serum during acute Q fever is associated with progression to a serologic profile indicative of chronic Q fever.

Wielders CC, Wijnbergen PC, Renders NH, Schellekens JJ, Schneeberger PM, Wever PC, Hermans MH.

J Clin Microbiol. 2013 Oct;51(10):3192-8. doi: 10.1128/JCM.00993-13. Epub 2013 Jul 17.

16.

Delayed diagnosis of chronic Q fever and cardiac valve surgery.

Kampschreur LM, Hoornenborg E, Renders NH, Oosterheert JJ, Haverman JF, Elsman P, Wever PC.

Emerg Infect Dis. 2013 May;19(5):768-70. doi: 10.3201/eid1905.120353.

17.

Epidemic Q fever in humans in the Netherlands.

van der Hoek W, Morroy G, Renders NH, Wever PC, Hermans MH, Leenders AC, Schneeberger PM.

Adv Exp Med Biol. 2012;984:329-64. doi: 10.1007/978-94-007-4315-1_17. Review.

PMID:
22711640
18.

Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemic.

Kampschreur LM, Oosterheert JJ, Hoepelman AI, Lestrade PJ, Renders NH, Elsman P, Wever PC.

Clin Vaccine Immunol. 2012 Aug;19(8):1165-9. doi: 10.1128/CVI.00185-12. Epub 2012 Jun 13.

19.

Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak.

Kampschreur LM, Hagenaars JC, Wielders CC, Elsman P, Lestrade PJ, Koning OH, Oosterheert JJ, Renders NH, Wever PC.

Epidemiol Infect. 2013 Apr;141(4):847-51. doi: 10.1017/S0950268812001203. Epub 2012 Jun 13.

PMID:
22691867
20.

Identification of risk factors for chronic Q fever, the Netherlands.

Kampschreur LM, Dekker S, Hagenaars JC, Lestrade PJ, Renders NH, de Jager-Leclercq MG, Hermans MH, Groot CA, Groenwold RH, Hoepelman AI, Wever PC, Oosterheert JJ.

Emerg Infect Dis. 2012 Apr;18(4):563-70. doi: 10.3201/eid1804.111478.

21.

Microbiological challenges in the diagnosis of chronic Q fever.

Kampschreur LM, Oosterheert JJ, Koop AM, Wegdam-Blans MC, Delsing CE, Bleeker-Rovers CP, De Jager-Leclercq MG, Groot CA, Sprong T, Nabuurs-Franssen MH, Renders NH, van Kasteren ME, Soethoudt Y, Blank SN, Pronk MJ, Groenwold RH, Hoepelman AI, Wever PC.

Clin Vaccine Immunol. 2012 May;19(5):787-90. doi: 10.1128/CVI.05724-11. Epub 2012 Mar 21.

22.

Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Notermans DW, Renders NH, Bijlmer HA, Lestrade PJ, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ; Dutch Q fever Consensus Group.

J Infect. 2012 Mar;64(3):247-59. doi: 10.1016/j.jinf.2011.12.014. Epub 2011 Dec 23. Review.

PMID:
22226692
23.

Follow-up of 686 patients with acute Q fever and detection of chronic infection.

van der Hoek W, Versteeg B, Meekelenkamp JC, Renders NH, Leenders AC, Weers-Pothoff I, Hermans MH, Zaaijer HL, Wever PC, Schneeberger PM.

Clin Infect Dis. 2011 Jun 15;52(12):1431-6. doi: 10.1093/cid/cir234.

PMID:
21628483
24.

Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting.

Jager MM, Weers-Pothoff G, Hermans MH, Meekelenkamp JC, Schellekens JJ, Renders NH, Leenders AC, Schneeberger PM, Wever PC.

Clin Vaccine Immunol. 2011 Jun;18(6):963-8. doi: 10.1128/CVI.00009-11. Epub 2011 Apr 20.

25.

Chronic Q fever-related dual-pathogen endocarditis: case series of three patients.

Kampschreur LM, Oosterheert JJ, de Vries Feyens CA, Delsing CE, Hermans MH, van Sluisveld IL, Lestrade PJ, Renders NH, Elsman P, Wever PC.

J Clin Microbiol. 2011 Apr;49(4):1692-4. doi: 10.1128/JCM.02596-10. Epub 2011 Feb 2.

26.

[Screening for chronic Q fever in symptomatic patients with an aortic aneurysm or prosthesis].

Wever PC, Arts CH, Groot CA, Lestrade PJ, Koning OH, Renders NH.

Ned Tijdschr Geneeskd. 2010;154:A2122. Dutch.

PMID:
20699030
27.

Methicillin-resistant Staphylococcus aureus in a beauty salon, the Netherlands.

Huijsdens XW, Janssen M, Renders NH, Leenders A, van Wijk P, van Santen Verheuvel MG, van Driel JK, Morroy G.

Emerg Infect Dis. 2008 Nov;14(11):1797-9. doi: 10.3201/eid1411.071297.

28.

[Clindamycin is unsuitable for the empirical treatment of infections due to pig-related methicillin-resistant Staphylococcus aureus (MRSA)].

Renders NH, Janssen MH, Leenders AC.

Ned Tijdschr Geneeskd. 2007 Oct 13;151(41):2277-80. Dutch.

PMID:
17987897
29.

[Diagnostic image (216). A man with a skin eruption].

Kraan EM, Renders NH.

Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2324. Dutch.

PMID:
15587050
30.

Nosocomial Mycobacterium bovis-bacille Calmette-Guérin infections due to contamination of chemotherapeutics: case finding and route of transmission.

Vos MC, de Haas PE, Verbrugh HA, Renders NH, Hartwig NG, de Man P, Kolk AH, van Deutekom H, Yntema JL, Vulto AG, Messemaker M, van Soolingen D.

J Infect Dis. 2003 Nov 1;188(9):1332-5. Epub 2003 Oct 15.

PMID:
14593590
31.

Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.

van Belkum A, Renders NH, Smith S, Overbeek SE, Verbrugh HA.

FEMS Immunol Med Microbiol. 2000 Jan;27(1):51-7.

32.

Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings.

Renders NH, Sijmons MA, van Belkum A, Overbeek SE, Mouton JW, Verbrugh HA.

Res Microbiol. 1997 Jun;148(5):447-54.

PMID:
9765823
33.

Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients.

Renders NH, van Belkum A, Overbeek SE, Mouton JW, Verbrugh HA.

Clin Microbiol Infect. 1997 Apr;3(2):216-221.

34.

[Gentamicin skin ointment: 200 kilos too much].

Renders NH, Kluytmans JA, Stolz E, Verbrugh HA.

Ned Tijdschr Geneeskd. 1995 Nov 11;139(45):2314-6. Dutch. Erratum in: Ned Tijdschr Geneeskd 1995 Dec 2;139(48):2536. Ned Tijdschr Geneeskd 1995 Dec 30;139(52):2768.

PMID:
7501065
35.

Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Renders NH, Kluytmans JA, Verbrugh HA.

J Clin Microbiol. 1995 Feb;33(2):508. No abstract available.

36.

Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.

van Bronswijk H, Verbrugh HA, Heezius HC, Renders NH, Fleer A, van der Meulen J, Oe PL, Verhoef J.

Immunology. 1989 May;67(1):81-6.

Supplemental Content

Loading ...
Support Center